These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Monoclonal antibody treatment for COVID-19 in solid organ transplant recipients. Sarrell BA; Bloch K; El Chediak A; Kumm K; Tracy K; Forbes RC; Langone A; Thomas L; Schlendorf K; Trindade AJ; Perri R; Wright P; Concepcion BP Transpl Infect Dis; 2022 Feb; 24(1):e13759. PubMed ID: 34787345 [TBL] [Abstract][Full Text] [Related]
11. SARS-CoV-2 infection and replication in human gastric organoids. Giobbe GG; Bonfante F; Jones BC; Gagliano O; Luni C; Zambaiti E; Perin S; Laterza C; Busslinger G; Stuart H; Pagliari M; Bortolami A; Mazzetto E; Manfredi A; Colantuono C; Di Filippo L; Pellegata AF; Panzarin V; Thapar N; Li VSW; Eaton S; Cacchiarelli D; Clevers H; Elvassore N; De Coppi P Nat Commun; 2021 Nov; 12(1):6610. PubMed ID: 34785679 [TBL] [Abstract][Full Text] [Related]
12. SARS-CoV-2 inhibits induction of the MHC class I pathway by targeting the STAT1-IRF1-NLRC5 axis. Yoo JS; Sasaki M; Cho SX; Kasuga Y; Zhu B; Ouda R; Orba Y; de Figueiredo P; Sawa H; Kobayashi KS Nat Commun; 2021 Nov; 12(1):6602. PubMed ID: 34782627 [TBL] [Abstract][Full Text] [Related]
13. S Protein, ACE2 and Host Cell Proteases in SARS-CoV-2 Cell Entry and Infectivity; Is Soluble ACE2 a Two Blade Sword? A Narrative Review. Nejat R; Torshizi MF; Najafi DJ Vaccines (Basel); 2023 Jan; 11(2):. PubMed ID: 36851081 [TBL] [Abstract][Full Text] [Related]
14. An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019: Implications for vascular and coagulation disease associated with severe acute respiratory syndrome coronavirus infection. Devaux CA; Camoin-Jau L Front Microbiol; 2022; 13():1042200. PubMed ID: 36519165 [TBL] [Abstract][Full Text] [Related]
15. Using host receptor as a decoy to treat COVID-19: a solution for immune escape? Huang KY; Lin MS; Yang PC EMBO Mol Med; 2022 Nov; 14(11):e16818. PubMed ID: 36256519 [TBL] [Abstract][Full Text] [Related]
16. Bioengineered angiotensin-converting-enzyme-2: a potential therapeutic option against SARS-CoV-2 infection. Maiti BK J Hum Hypertens; 2022 May; 36(5):488-492. PubMed ID: 34773078 [TBL] [Abstract][Full Text] [Related]
17. The Race for ACE: Targeting Angiotensin-Converting Enzymes (ACE) in SARS-CoV-2 Infection. Schieffer E; Schieffer B J Renin Angiotensin Aldosterone Syst; 2022; 2022():2549063. PubMed ID: 35685188 [TBL] [Abstract][Full Text] [Related]
18. ACE2 Shedding and the Role in COVID-19. Wang J; Zhao H; An Y Front Cell Infect Microbiol; 2021; 11():789180. PubMed ID: 35096642 [TBL] [Abstract][Full Text] [Related]
19. Regulation of Angiotensin-Converting Enzyme 2: A Potential Target to Prevent COVID-19? Hu Y; Liu L; Lu X Front Endocrinol (Lausanne); 2021; 12():725967. PubMed ID: 34745001 [TBL] [Abstract][Full Text] [Related]